Chemcon Speciality Chemicals Limited has informed the Exchange about Investor Presentation

Chemcon reported Q4FY26 revenue of ₹75 crore, up 37% YoY, with FY26 revenue of ₹240 crore growing 16% YoY. Q4 showed strong recovery driven by higher volumes and better realizations in both Organic and Inorganic Chemicals segments. Newer products like Bromobenzene and 2-Bromo are gaining traction in pharmaceutical, agrochemical, and aromatic chemical industries. The company acquired Shivam Petrochem Industries for ₹36 crore via slump sale to expand into bulk drugs, chemical intermediates, and specialty chemicals. However, full-year EBITDA margin declined to 12.6% from 15.8% in FY25, and PAT margin fell to 9.8% from 11.8%, reflecting pricing pressure and subdued demand conditions. Two new expansion plants (P10 and P11) are expected to commission in Q1 FY27.